Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay
Hematol Oncol
.
2019 Aug;37(3):316-318.
doi: 10.1002/hon.2611.
Epub 2019 Apr 26.
Authors
Yoshikazu Kamiya
1
,
Takaaki Chou
2
,
Hirokazu Murakami
3
,
Hiroshi Handa
4
,
Shuji Ozaki
5
,
Chihiro Shimazaki
6
,
Shin-Ichi Fuchida
6
,
Jun Okada
7
,
Junji Itoh
8
,
Satoru Sugiyama
9
,
Kazuyuki Shimizu
1
Affiliations
1
Hematology/Oncology, Higashi Nagoya National Hospital, Nagoya, Japan.
2
Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.
3
Department of Laboratory Sciences, Gunma University, Maebashi, Japan.
4
Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan.
5
Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
6
Japan Community Healthcare Organization, Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
7
Marketing and Technical Support Department, Medical and Biological Laboratories Co., Ltd, Nagoya, Japan.
8
Department of Clinical Laboratory, Nagoya City Midori General Hospital, Nagoya, Japan.
9
The Institute of Applied Biochemistry, Kani, Japan.
PMID:
30938836
DOI:
10.1002/hon.2611
No abstract available
Publication types
Letter
MeSH terms
Female
Humans
Immunoglobulin Heavy Chains / blood*
Immunoglobulin Light Chains / blood*
Male
Multiple Myeloma / blood*
Multiple Myeloma / therapy
Substances
Immunoglobulin Heavy Chains
Immunoglobulin Light Chains